Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Long-term Follow-up of Gene Therapy for Radiation-Induced XerostomiaNCT06544798MeiraGTx, LLCPhase 2Enrolling by invitation2032-02Estimated
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 YrsNCT06553547ArdelyxPhase 2Completed2026-07-07Actual
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)NCT06553768MIRMPhase 3Active not recruiting2026-10Estimated
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2NCT06555783Alkermes, Inc.Phase 2Completed2025-11-11Actual
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKNCT06556368KODPhase 3Active not recruiting2026-08Estimated
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaNCT06556563NovoCure GmbHPhase 3Recruiting2029-04Estimated
LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)NCT06558799NovoCure GmbHPhase 2Terminated2026-02-23Actual
A Study of Obexelimab in Patients With Systemic Lupus ErythematosusNCT06559163Zenas BioPharma (USA), LLCPhase 2Active not recruiting2026-09Estimated
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaNCT06561048CRVSPhase 3Recruiting2027-11Estimated
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)NCT06564311Zenas BioPharma (USA), LLCPhase 2Active not recruiting2025-08-28Actual
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer PatientsNCT06564324NUVBPhase 3Recruiting2029-01Estimated
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of ObesityNCT06565611PTNPhase 2Active not recruiting2025-02-05Actual
Continuation Protocol for Obstructive Sleep Apnea (OSA)NCT06566820ApnimedPhase 3Enrolling by invitation2026-06-30Estimated
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBCNCT06567743CGONPhase 2Recruiting2027-03-31Estimated
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)NCT06568367AXSMPhase 3Recruiting2026-12Estimated
A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)NCT06568627MDWDPhase 3Recruiting2026-12Estimated
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerNCT06568692Processa PharmaceuticalsPhase 2Recruiting2026-09Estimated
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs PlaceboNCT06577090SKYEPhase 2Active not recruiting2026-11-20Estimated
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaNCT06581406Replimune, Inc.Phase 2, Phase 3Recruiting2030-01Estimated
Performance of the Travoprost Intraocular ImplantNCT06582732Glaukos CorporationPhase 2Completed2023-11-02Actual
Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic DermatitisNCT06585202ACRSPhase 2Completed2025-03-13Actual
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque PsoriasisNCT06586112ALMSPhase 3Completed2025-09-19Actual
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person SyndromeNCT06588491Kyverna TherapeuticsPhase 2Completed2026-06-25Actual
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.NCT06588686Vicore Pharma ABPhase 2Active not recruiting2027-05Estimated
A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001NCT06588738ALMSPhase 3Completed2025-09-23Actual
Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentNCT06590090XBITPhase 2Not yet recruiting2027-01-15Estimated
Open-Label Extension Study of SetmelanotideNCT06596135RYTMPhase 3Completed2026-06-24Actual
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)NCT06602193DNLIPhase 2Active not recruiting2027-03Estimated
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NCT06602271Ensysce BiosciencesPhase 3Recruiting2026-08Estimated
A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis SuppurativaNCT06603077AVTXPhase 2Completed2026-02-23Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.